Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
21.02 EUR | -0.14% | +2.20% | +25.03% |
11:12am | DB and Berenberg raise Diploma price target | AN |
May. 13 | Jefferies Keeps GSK at Buy, Lifts PT | MT |
Sales 2024 * | 31.61B 39.63B 36.73B | Sales 2025 * | 33.56B 42.07B 39B | Capitalization | 73.81B 92.52B 85.76B |
---|---|---|---|---|---|
Net income 2024 * | 5.54B 6.95B 6.44B | Net income 2025 * | 6.49B 8.14B 7.55B | EV / Sales 2024 * | 2.72 x |
Net Debt 2024 * | 12.3B 15.42B 14.3B | Net Debt 2025 * | 9.1B 11.41B 10.57B | EV / Sales 2025 * | 2.47 x |
P/E ratio 2024 * |
13.3
x | P/E ratio 2025 * |
11.4
x | Employees | 70,212 |
Yield 2024 * |
3.37% | Yield 2025 * |
3.49% | Free-Float | 94.38% |
Latest transcript on GSK plc
1 day | -0.14% | ||
1 week | +2.20% | ||
Current month | +7.53% | ||
1 month | +6.86% | ||
3 months | +6.99% | ||
6 months | +31.99% | ||
Current year | +25.03% |
Managers | Title | Age | Since |
---|---|---|---|
Emma Walmsley
CEO | Chief Executive Officer | 55 | 10-04-30 |
Julie Brown
DFI | Director of Finance/CFO | 62 | 23-04-30 |
James Ford
CMP | Compliance Officer | - | 95-07-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Julie Brown
DFI | Director of Finance/CFO | 62 | 23-04-30 |
Jonathan Symonds
CHM | Chairman | 66 | 19-08-31 |
Hal Barron
BRD | Director/Board Member | 62 | 17-12-31 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-14 | 20.86 | -0.90% | 3 360 |
24-05-13 | 21.05 | +1.59% | 1,858 |
24-05-10 | 20.72 | +0.53% | 2,000 |
24-05-09 | 20.61 | +1.03% | 4 |
24-05-08 | 20.4 | -0.05% | 1,240 |
Delayed Quote Deutsche Boerse AG, May 14, 2024 at 04:15 am EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+29.98% | 682B | |
+31.66% | 586B | |
-3.52% | 364B | |
+18.59% | 327B | |
+4.07% | 285B | |
+16.51% | 240B | |
+9.37% | 209B | |
-8.79% | 203B | |
+7.09% | 165B |
- Stock Market
- Equities
- GSK Stock
- GS71 Stock